(+)-pilocarpine multiple interactions EXP 6480464 Ketamine inhibits the reaction [Pilocarpine results in increased expression of NTRK2 mRNA] more ... CTD PMID:19686240 , PMID:8635431 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of NTRK2 mRNA CTD PMID:15183516 more ... (+)-syringaresinol beta-D-glucoside multiple interactions ISO RGD:11023 6480464 [acanthoside B co-treated with Scopolamine] results in increased phosphorylation of NTRK2 protein CTD PMID:31077737 (20S)-ginsenoside Rg3 multiple interactions ISO RGD:731305 6480464 [staurosporine aglycone binds to and results in decreased activity of NTRK2 protein] inhibits the reaction [[Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein]] more ... CTD PMID:24394491 (20S)-ginsenoside Rg3 multiple interactions ISO RGD:11023 6480464 [Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of NTRK2 protein modified form] more ... CTD PMID:24394491 (S)-amphetamine increases expression ISO RGD:11023 6480464 Dextroamphetamine results in increased expression of NTRK2 mRNA CTD PMID:18681898 (S)-nicotine increases expression ISO RGD:731305 6480464 Nicotine results in increased expression of NTRK2 protein CTD PMID:16790237 (S)-nicotine multiple interactions ISO RGD:731305 6480464 methyllycaconitine inhibits the reaction [Nicotine results in increased expression of NTRK2 protein] CTD PMID:16790237 1,2-dichloroethane decreases expression ISO RGD:11023 6480464 ethylene dichloride results in decreased expression of NTRK2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:11023 6480464 1, 2-Dimethylhydrazine results in decreased expression of NTRK2 mRNA CTD PMID:22206623 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile multiple interactions ISO RGD:11023 6480464 Citalopram results in increased phosphorylation of and results in increased activity of NTRK2 protein CTD PMID:21666748 1-fluoro-2,4-dinitrobenzene increases expression ISO RGD:731305 6480464 Dinitrofluorobenzene results in increased expression of NTRK2 mRNA CTD PMID:23999411 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of NTRK2 mRNA CTD PMID:12075121 , PMID:15901920 17beta-estradiol decreases expression ISO RGD:11023 6480464 Estradiol results in decreased expression of NTRK2 mRNA CTD PMID:25210133 17beta-estradiol multiple interactions ISO RGD:11023 6480464 ESR1 protein promotes the reaction [Estradiol results in decreased expression of NTRK2 mRNA] CTD PMID:25210133 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11023 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of NTRK2 gene CTD PMID:21212295 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11023 6480464 Tetrachlorodibenzodioxin results in decreased expression of NTRK2 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11023 6480464 Tetrachlorodibenzodioxin affects the expression of NTRK2 mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:11023 6480464 Tetrachlorodibenzodioxin results in increased expression of NTRK2 mRNA CTD PMID:19465110 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 , PMID:32119087 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731305 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NTRK2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases expression ISO RGD:11023 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of NTRK2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:11023 6480464 Fenretinide results in decreased expression of NTRK2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:731305 6480464 Decitabine results in increased expression of NTRK2 mRNA CTD PMID:19151715 5-fluorouracil decreases expression ISO RGD:731305 6480464 Fluorouracil results in decreased expression of NTRK2 protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:731305 6480464 NTRK2 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NTRK2 mRNA CTD PMID:24780913 acrolein decreases expression EXP 6480464 Acrolein results in decreased expression of NTRK2 protein CTD PMID:29355571 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of NTRK2 mRNA CTD PMID:28959563 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of NTRK2 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:731305 6480464 Aflatoxin B1 results in decreased methylation of NTRK2 gene CTD PMID:27153756 aldrin multiple interactions ISO RGD:731305 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK2 mRNA CTD PMID:28263720 all-trans-retinoic acid multiple interactions ISO RGD:731305 6480464 [Tretinoin co-treated with SHH protein co-treated with FGF8 protein] results in increased expression of NTRK2 mRNA CTD PMID:17085092 all-trans-retinoic acid increases expression ISO RGD:731305 6480464 Tretinoin results in increased expression of NTRK2 mRNA, Tretinoin results in increased expression of NTRK2 protein CTD PMID:16051641 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NTRK2 mRNA CTD PMID:16483693 androgen antagonist multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 Aroclor 1254 multiple interactions ISO RGD:731305 6480464 [staurosporine aglycone binds to and results in decreased activity of NTRK2 protein] inhibits the reaction [[Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein]] more ... CTD PMID:24394491 Aroclor 1254 multiple interactions ISO RGD:11023 6480464 [Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of NTRK2 protein modified form], [staurosporine aglycone binds to and results in decreased activity of NTRK2 protein] inhibits the reaction [[Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] results in decreased susceptibility to Chlorodiphenyl (54% Chlorine)] CTD PMID:24394491 Aroclor 1254 decreases expression ISO RGD:11023 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NTRK2 protein modified form CTD PMID:24394491 arsane decreases phosphorylation EXP 6480464 Arsenic results in decreased phosphorylation of NTRK2 protein CTD PMID:28903487 arsane multiple interactions EXP 6480464 BDNF protein inhibits the reaction [Arsenic results in decreased phosphorylation of NTRK2 protein], NOG protein inhibits the reaction [Arsenic results in decreased phosphorylation of NTRK2 protein] CTD PMID:28903487 arsenic atom decreases phosphorylation EXP 6480464 Arsenic results in decreased phosphorylation of NTRK2 protein CTD PMID:28903487 arsenic atom multiple interactions EXP 6480464 BDNF protein inhibits the reaction [Arsenic results in decreased phosphorylation of NTRK2 protein], NOG protein inhibits the reaction [Arsenic results in decreased phosphorylation of NTRK2 protein] CTD PMID:28903487 arsenous acid increases sumoylation ISO RGD:731305 6480464 Arsenic Trioxide results in increased sumoylation of NTRK2 protein CTD PMID:28318385 arsenous acid multiple interactions ISO RGD:11023 6480464 Arsenic Trioxide promotes the reaction [Reserpine results in decreased expression of NTRK2 protein] CTD PMID:26114099 arsenous acid increases expression ISO RGD:731305 6480464 Arsenic Trioxide results in increased expression of NTRK2 mRNA, Arsenic Trioxide results in increased expression of NTRK2 protein CTD PMID:16569477 , PMID:29898774 arsenous acid decreases expression ISO RGD:731305 6480464 Arsenic Trioxide results in decreased expression of NTRK2 mRNA, Arsenic Trioxide results in decreased expression of NTRK2 protein CTD PMID:16711005 , PMID:26705709 atrazine decreases expression ISO RGD:731305 6480464 Atrazine results in decreased expression of NTRK2 mRNA CTD PMID:22378314 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of NTRK2 gene CTD PMID:28931070 benzo[a]pyrene multiple interactions ISO RGD:11023 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of NTRK2 mRNA] CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:11023 6480464 Benzo(a)pyrene results in increased methylation of NTRK2 3' UTR, Benzo(a)pyrene results in increased methylation of NTRK2 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:731305 6480464 Benzo(a)pyrene affects the methylation of NTRK2 5' UTR, Benzo(a)pyrene affects the methylation of NTRK2 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:731305 6480464 Benzo(a)pyrene results in increased methylation of NTRK2 3' UTR, Benzo(a)pyrene results in increased methylation of NTRK2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:11023 6480464 Benzo(a)pyrene results in decreased expression of NTRK2 mRNA CTD PMID:21569818 , PMID:22610609 benzo[a]pyrene increases expression ISO RGD:11023 6480464 Benzo(a)pyrene results in increased expression of NTRK2 mRNA CTD PMID:22228805 benzo[e]pyrene decreases methylation ISO RGD:731305 6480464 benzo(e)pyrene results in decreased methylation of NTRK2 promoter CTD PMID:30157460 bis(2-chloroethyl) sulfide decreases expression ISO RGD:11023 6480464 Mustard Gas results in decreased expression of NTRK2 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NTRK2 mRNA CTD PMID:12075121 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NTRK2 mRNA CTD PMID:30816183 bisphenol A decreases expression ISO RGD:11023 6480464 bisphenol A results in decreased expression of NTRK2 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:731305 6480464 bisphenol A results in increased expression of NTRK2 mRNA CTD PMID:27685785 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NTRK2 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NTRK2 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of NTRK2 mRNA CTD PMID:25607892 bisphenol A increases expression ISO RGD:11023 6480464 bisphenol A results in increased expression of NTRK2 mRNA CTD PMID:26869994 bisphenol F multiple interactions ISO RGD:731305 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NTRK2 mRNA CTD PMID:28628672 bisphenol F decreases expression ISO RGD:11023 6480464 bisphenol F results in decreased expression of NTRK2 mRNA CTD PMID:30951980 buprenorphine decreases phosphorylation EXP 6480464 Buprenorphine results in decreased phosphorylation of NTRK2 protein CTD PMID:24321744 buta-1,3-diene decreases expression ISO RGD:11023 6480464 1, 3-butadiene results in decreased expression of NTRK2 mRNA CTD PMID:29038090 butanal increases expression ISO RGD:731305 6480464 butyraldehyde results in increased expression of NTRK2 mRNA CTD PMID:26079696 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NTRK2 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of NTRK2 mRNA CTD PMID:25607892 cadmium atom multiple interactions ISO RGD:11023 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of NTRK2 mRNA CTD PMID:31904401 cadmium dichloride multiple interactions ISO RGD:11023 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of NTRK2 mRNA CTD PMID:31904401 cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of NTRK2 gene CTD PMID:30521419 carbon nanotube affects expression ISO RGD:11023 6480464 Nanotubes, Carbon affects the expression of NTRK2 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:11023 6480464 Nanotubes, Carbon analog results in increased expression of NTRK2 mRNA, Nanotubes, Carbon results in increased expression of NTRK2 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:11023 6480464 Nanotubes, Carbon analog results in decreased expression of NTRK2 mRNA CTD PMID:25620056 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of NTRK2 mRNA CTD PMID:18502319 choline multiple interactions ISO RGD:11023 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of NTRK2 mRNA more ... CTD PMID:20938992 , PMID:29246445 citalopram multiple interactions ISO RGD:11023 6480464 Citalopram results in increased phosphorylation of and results in increased activity of NTRK2 protein CTD PMID:21666748 Citreoviridin increases expression ISO RGD:11023 6480464 citreoviridin results in increased expression of NTRK2 mRNA CTD PMID:30071239 clomipramine increases phosphorylation ISO RGD:11023 6480464 Clomipramine results in increased phosphorylation of NTRK2 protein CTD PMID:22396798 cocaine multiple interactions ISO RGD:11023 6480464 Cocaine affects the reaction [NTRK2 protein affects the expression of KCNA2 mRNA] more ... CTD PMID:20947769 cocaine decreases phosphorylation ISO RGD:11023 6480464 Cocaine results in decreased phosphorylation of NTRK2 protein CTD PMID:24358339 cocaine affects expression EXP 6480464 Cocaine affects the expression of NTRK2 mRNA, Cocaine affects the expression of NTRK2 protein CTD PMID:12358776 , PMID:20187946 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of NTRK2 mRNA CTD PMID:16423334 cocaine decreases expression ISO RGD:731305 6480464 Cocaine results in decreased expression of NTRK2 mRNA CTD PMID:15009677 , PMID:16710320 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of NTRK2 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of NTRK2 mRNA CTD PMID:26033743 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [sodium arsenite results in decreased expression of NTRK2 protein] CTD PMID:29723552 cyclophosphamide multiple interactions EXP 6480464 Cyclophosphamide results in increased phosphorylation of and results in increased expression of NTRK2 protein CTD PMID:12412144 cyclosporin A increases methylation ISO RGD:731305 6480464 Cyclosporine results in increased methylation of NTRK2 promoter CTD PMID:27989131 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of NTRK2 mRNA CTD PMID:22528246 cyproconazole increases expression ISO RGD:11023 6480464 cyproconazole results in increased expression of NTRK2 mRNA CTD PMID:22045034 DDD multiple interactions ISO RGD:731305 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK2 mRNA CTD PMID:28263720 DDE multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 DDE multiple interactions ISO RGD:731305 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK2 mRNA CTD PMID:28263720 DDT multiple interactions ISO RGD:731305 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK2 mRNA CTD PMID:28263720 deoxynivalenol decreases expression ISO RGD:731305 6480464 deoxynivalenol results in decreased expression of NTRK2 mRNA CTD PMID:31863870 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of NTRK2 mRNA CTD PMID:29111458 dexamethasone multiple interactions ISO RGD:731305 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NTRK2 mRNA CTD PMID:28628672 diarsenic trioxide increases sumoylation ISO RGD:731305 6480464 Arsenic Trioxide results in increased sumoylation of NTRK2 protein CTD PMID:28318385 diarsenic trioxide multiple interactions ISO RGD:11023 6480464 Arsenic Trioxide promotes the reaction [Reserpine results in decreased expression of NTRK2 protein] CTD PMID:26114099 diarsenic trioxide decreases expression ISO RGD:731305 6480464 Arsenic Trioxide results in decreased expression of NTRK2 mRNA, Arsenic Trioxide results in decreased expression of NTRK2 protein CTD PMID:16711005 , PMID:26705709 diarsenic trioxide increases expression ISO RGD:731305 6480464 Arsenic Trioxide results in increased expression of NTRK2 mRNA, Arsenic Trioxide results in increased expression of NTRK2 protein CTD PMID:16569477 , PMID:29898774 diazinon affects expression EXP 6480464 Diazinon affects the expression of NTRK2 mRNA CTD PMID:18502319 , PMID:19130878 dibutyl phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of NTRK2 mRNA CTD PMID:19130878 dieldrin multiple interactions ISO RGD:731305 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK2 mRNA CTD PMID:28263720 dioxygen multiple interactions EXP 6480464 EPAS1 mutant form inhibits the reaction [Oxygen deficiency results in increased expression of NTRK2 mRNA] CTD PMID:26095976 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of NTRK2 mRNA, Oxygen deficiency results in increased expression of NTRK2 protein CTD PMID:26095976 disodium selenite multiple interactions ISO RGD:11023 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NTRK2 mRNA, Sodium Selenite promotes the reaction [Hydrogen Peroxide results in decreased expression of NTRK2 mRNA] CTD PMID:17997286 , PMID:23274088 disodium selenite decreases expression ISO RGD:11023 6480464 Sodium Selenite results in decreased expression of NTRK2 mRNA CTD PMID:23274088 diuron decreases expression EXP 6480464 Diuron results in decreased expression of NTRK2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:731305 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:731305 6480464 Doxorubicin results in decreased expression of NTRK2 mRNA CTD PMID:29803840 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of NTRK2 mRNA CTD PMID:32289291 doxorubicin increases expression ISO RGD:731305 6480464 Doxorubicin results in increased expression of NTRK2 mRNA CTD PMID:30031762 echinacoside multiple interactions EXP 6480464 echinacoside inhibits the reaction [Rotenone results in decreased phosphorylation of NTRK2 protein], staurosporine aglycone inhibits the reaction [echinacoside results in increased phosphorylation of NTRK2 protein] CTD PMID:23189969 echinacoside multiple interactions ISO RGD:731305 6480464 echinacoside inhibits the reaction [Rotenone results in decreased phosphorylation of NTRK2 protein], staurosporine aglycone inhibits the reaction [echinacoside inhibits the reaction [Rotenone results in decreased phosphorylation of NTRK2 protein]] CTD PMID:23189969 echinacoside increases phosphorylation EXP 6480464 echinacoside results in increased phosphorylation of NTRK2 protein CTD PMID:23189969 Endrin multiple interactions ISO RGD:731305 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK2 mRNA CTD PMID:28263720 entinostat decreases expression ISO RGD:731305 6480464 entinostat results in decreased expression of NTRK2 mRNA CTD PMID:27188386 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NTRK2 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of NTRK2 mRNA CTD PMID:25607892 epoxiconazole multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 ethanol increases expression ISO RGD:11023 6480464 Ethanol results in increased expression of NTRK2 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:11023 6480464 Ethanol affects the expression of and affects the splicing of NTRK2 mRNA CTD PMID:30319688 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of NTRK2 mRNA CTD PMID:18035473 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of NTRK2 mRNA, Fluoxetine results in increased expression of NTRK2 mRNA alternative form CTD PMID:15456934 , PMID:8601816 fluoxetine multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [NTRK2 protein binds to AP2M1 protein] CTD PMID:31631060 fluoxetine increases phosphorylation ISO RGD:11023 6480464 Fluoxetine results in increased phosphorylation of NTRK2 protein CTD PMID:22396798 fluoxetine multiple interactions ISO RGD:11023 6480464 Fluoxetine inhibits the reaction [NTRK2 protein binds to AP2A2 protein] more ... CTD PMID:21666748 , PMID:31631060 folic acid multiple interactions ISO RGD:11023 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NTRK2 mRNA CTD PMID:20938992 folic acid increases expression ISO RGD:11023 6480464 Folic Acid results in increased expression of NTRK2 mRNA, Folic Acid results in increased expression of NTRK2 protein CTD PMID:30920123 folic acid decreases expression ISO RGD:11023 6480464 Folic Acid results in decreased expression of NTRK2 mRNA CTD PMID:25629700 gamma-hexachlorocyclohexane multiple interactions ISO RGD:731305 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK2 mRNA CTD PMID:28263720 genistein increases expression EXP 6480464 Genistein results in increased expression of NTRK2 mRNA CTD PMID:12075121 glyphosate increases expression ISO RGD:11023 6480464 glyphosate results in increased expression of NTRK2 mRNA CTD PMID:32067069 graphite affects expression EXP 6480464 Graphite affects the expression of NTRK2 mRNA CTD PMID:29933104 heroin increases expression ISO RGD:731305 6480464 Heroin results in increased expression of NTRK2 mRNA CTD PMID:16710320 hydrogen peroxide decreases expression ISO RGD:11023 6480464 Hydrogen Peroxide results in decreased expression of NTRK2 mRNA CTD PMID:17997286 hydrogen peroxide decreases expression ISO RGD:731305 6480464 Hydrogen Peroxide results in decreased expression of NTRK2 mRNA CTD PMID:26339600 hydrogen peroxide multiple interactions ISO RGD:11023 6480464 Sodium Selenite promotes the reaction [Hydrogen Peroxide results in decreased expression of NTRK2 mRNA] CTD PMID:17997286 imipramine multiple interactions ISO RGD:11023 6480464 Imipramine inhibits the reaction [NTRK2 protein binds to AP2M1 protein] more ... CTD PMID:21666748 more ... imipramine increases phosphorylation ISO RGD:11023 6480464 Imipramine results in increased phosphorylation of NTRK2 protein CTD PMID:22396798 indometacin multiple interactions ISO RGD:731305 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NTRK2 mRNA CTD PMID:28628672 isotretinoin increases expression ISO RGD:731305 6480464 Isotretinoin results in increased expression of NTRK2 mRNA CTD PMID:20436886 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of NTRK2 mRNA CTD PMID:19700661 ketamine multiple interactions EXP 6480464 Ketamine inhibits the reaction [Pilocarpine results in increased expression of NTRK2 mRNA] CTD PMID:8635431 ketamine multiple interactions ISO RGD:11023 6480464 Ketamine inhibits the reaction [NTRK2 protein binds to AP2M1 protein] CTD PMID:31631060 L-ascorbic acid increases expression ISO RGD:11023 6480464 Ascorbic Acid results in increased expression of NTRK2 mRNA CTD PMID:15305145 L-methionine multiple interactions ISO RGD:11023 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NTRK2 mRNA CTD PMID:20938992 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of NTRK2 protein CTD PMID:27492863 lead(0) multiple interactions EXP 6480464 Lead results in decreased expression of [NTRK2 protein binds to NGFR protein], Lead results in decreased phosphorylation of and results in decreased expression of NTRK2 protein CTD PMID:22345308 lead(0) affects splicing ISO RGD:731305 6480464 Lead affects the splicing of NTRK2 mRNA CTD PMID:28903495 lead(2+) multiple interactions EXP 6480464 Lead results in decreased expression of [NTRK2 protein binds to NGFR protein], Lead results in decreased phosphorylation of and results in decreased expression of NTRK2 protein CTD PMID:22345308 lead(2+) affects splicing ISO RGD:731305 6480464 Lead affects the splicing of NTRK2 mRNA CTD PMID:28903495 linuron multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 lipopolysaccharide decreases methylation ISO RGD:11023 6480464 Lipopolysaccharides results in decreased methylation of NTRK2 gene CTD PMID:21212295 lipopolysaccharide multiple interactions ISO RGD:11023 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of NTRK2 gene CTD PMID:21212295 maneb multiple interactions ISO RGD:11023 6480464 [Maneb co-treated with Paraquat] results in decreased expression of NTRK2 mRNA more ... CTD PMID:23963992 manganese(II) chloride decreases expression ISO RGD:11023 6480464 manganese chloride results in decreased expression of NTRK2 protein modified form CTD PMID:25698507 melatonin multiple interactions ISO RGD:11023 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of NTRK2 mRNA], Melatonin inhibits the reaction [Scopolamine results in decreased expression of NTRK2 protein] CTD PMID:23963992 , PMID:29476728 methapyrilene decreases methylation ISO RGD:731305 6480464 Methapyrilene results in decreased methylation of NTRK2 promoter CTD PMID:30157460 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of NTRK2 gene CTD PMID:23303685 methylglyoxal multiple interactions ISO RGD:731305 6480464 sulforafan inhibits the reaction [Pyruvaldehyde results in decreased expression of NTRK2 protein] CTD PMID:25933243 methylglyoxal decreases expression ISO RGD:731305 6480464 Pyruvaldehyde results in decreased expression of NTRK2 protein CTD PMID:25933243 methyllycaconitine multiple interactions ISO RGD:731305 6480464 methyllycaconitine inhibits the reaction [Nicotine results in increased expression of NTRK2 protein] CTD PMID:16790237 methylmercury chloride affects expression ISO RGD:11023 6480464 methylmercuric chloride affects the expression of NTRK2 mRNA CTD PMID:21613230 methylphenidate multiple interactions ISO RGD:731305 6480464 [staurosporine aglycone binds to and results in decreased activity of NTRK2 protein] inhibits the reaction [Methylphenidate inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein]] CTD PMID:24394491 N-acetyl-L-cysteine multiple interactions ISO RGD:11023 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NTRK2 protein] CTD PMID:28499986 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of NTRK2 gene CTD PMID:16495775 naphthalene increases expression ISO RGD:11023 6480464 naphthalene results in increased expression of NTRK2 mRNA CTD PMID:18978301 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of NTRK2 protein CTD PMID:17337753 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of NTRK2 mRNA CTD PMID:19130878 nicotine increases expression ISO RGD:731305 6480464 Nicotine results in increased expression of NTRK2 protein CTD PMID:16790237 nicotine multiple interactions ISO RGD:731305 6480464 methyllycaconitine inhibits the reaction [Nicotine results in increased expression of NTRK2 protein] CTD PMID:16790237 nicotinic acid increases expression EXP 6480464 Niacin results in increased expression of NTRK2 protein CTD PMID:20671245 papaverine increases expression EXP 6480464 Papaverine results in increased expression of NTRK2 mRNA CTD PMID:8601816 paracetamol multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 paracetamol multiple interactions ISO RGD:11023 6480464 [Acetaminophen co-treated with Win 55212-2] results in decreased expression of NTRK2 mRNA CTD PMID:30165669 paraquat decreases expression ISO RGD:11023 6480464 Paraquat results in decreased expression of NTRK2 mRNA CTD PMID:21371552 paraquat multiple interactions ISO RGD:11023 6480464 [Maneb co-treated with Paraquat] results in decreased expression of NTRK2 mRNA more ... CTD PMID:23963992 Phenelzine multiple interactions ISO RGD:11023 6480464 Phenelzine inhibits the reaction [NTRK2 protein binds to AP2M1 protein] CTD PMID:31631060 phenobarbital increases expression ISO RGD:11023 6480464 Phenobarbital results in increased expression of NTRK2 mRNA CTD PMID:21335049 phenobarbital decreases expression ISO RGD:11023 6480464 Phenobarbital results in decreased expression of NTRK2 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:731305 6480464 Phenylmercuric Acetate results in increased expression of NTRK2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731305 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NTRK2 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:11023 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of NTRK2 mRNA CTD PMID:31904401 physostigmine multiple interactions ISO RGD:11023 6480464 Physostigmine inhibits the reaction [Streptozocin results in decreased phosphorylation of NTRK2 protein] CTD PMID:28499986 pirinixic acid decreases expression ISO RGD:11023 6480464 pirinixic acid results in decreased expression of NTRK2 mRNA CTD PMID:23811191 ponatinib decreases activity ISO RGD:731305 6480464 ponatinib results in decreased activity of NTRK2 protein CTD PMID:19878872 prochloraz multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 procymidone multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 Ptaquiloside multiple interactions ISO RGD:11023 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NTRK2 mRNA CTD PMID:23274088 Ptaquiloside decreases expression ISO RGD:11023 6480464 ptaquiloside results in decreased expression of NTRK2 mRNA CTD PMID:23274088 reboxetine multiple interactions ISO RGD:11023 6480464 reboxetine results in increased phosphorylation of and results in increased activity of NTRK2 protein CTD PMID:21666748 reserpine decreases expression ISO RGD:11023 6480464 Reserpine results in decreased expression of NTRK2 protein CTD PMID:26114099 reserpine multiple interactions ISO RGD:11023 6480464 arsenic trioxide promotes the reaction [Reserpine results in decreased expression of NTRK2 protein] CTD PMID:26114099 rolipram increases expression EXP 6480464 Rolipram results in increased expression of NTRK2 mRNA CTD PMID:8601816 rolipram multiple interactions ISO RGD:11023 6480464 Rolipram inhibits the reaction [NTRK2 protein binds to AP2M1 protein] CTD PMID:31631060 rotenone decreases phosphorylation EXP 6480464 Rotenone results in decreased phosphorylation of NTRK2 protein CTD PMID:23189969 rotenone multiple interactions EXP 6480464 echinacoside inhibits the reaction [Rotenone results in decreased phosphorylation of NTRK2 protein] CTD PMID:23189969 rotenone decreases phosphorylation ISO RGD:731305 6480464 Rotenone results in decreased phosphorylation of NTRK2 protein CTD PMID:23189969 rotenone multiple interactions ISO RGD:731305 6480464 echinacoside inhibits the reaction [Rotenone results in decreased phosphorylation of NTRK2 protein], staurosporine aglycone inhibits the reaction [echinacoside inhibits the reaction [Rotenone results in decreased phosphorylation of NTRK2 protein]] CTD PMID:23189969 sarin increases expression ISO RGD:731305 6480464 Sarin results in increased expression of NTRK2 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:731305 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 scopolamine multiple interactions EXP 6480464 Scopolamine inhibits the reaction [Pilocarpine results in increased expression of NTRK2 mRNA] CTD PMID:8635431 scopolamine decreases expression ISO RGD:11023 6480464 Scopolamine results in decreased expression of NTRK2 protein CTD PMID:29476728 scopolamine multiple interactions ISO RGD:11023 6480464 [acanthoside B co-treated with Scopolamine] results in increased phosphorylation of NTRK2 protein more ... CTD PMID:29476728 , PMID:31077737 simvastatin multiple interactions ISO RGD:731305 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Dichlorodiphenyldichloroethane co-treated with DDT co-treated with Simvastatin] results in increased expression of NTRK2 mRNA CTD PMID:28263720 sodium arsenate increases expression ISO RGD:11023 6480464 sodium arsenate results in increased expression of NTRK2 mRNA CTD PMID:30953684 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of NTRK2 protein CTD PMID:29723552 sodium arsenite multiple interactions EXP 6480464 Curcumin inhibits the reaction [sodium arsenite results in decreased expression of NTRK2 protein] CTD PMID:29723552 sodium dodecyl sulfate affects response to substance ISO RGD:731305 6480464 NTRK2 SNP affects the susceptibility to Sodium Dodecyl Sulfate CTD PMID:27206134 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of NTRK2 protein CTD PMID:30130557 sodium fluoride decreases expression ISO RGD:731305 6480464 Sodium Fluoride results in decreased expression of NTRK2 protein CTD PMID:30130557 sodium fluoride multiple interactions ISO RGD:731305 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Fluoride results in decreased expression of NTRK2 protein] CTD PMID:30130557 Soman increases expression EXP 6480464 Soman results in increased expression of NTRK2 mRNA CTD PMID:19281266 streptozocin decreases phosphorylation ISO RGD:11023 6480464 Streptozocin results in decreased phosphorylation of NTRK2 protein CTD PMID:28499986 streptozocin multiple interactions ISO RGD:11023 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NTRK2 protein], Physostigmine inhibits the reaction [Streptozocin results in decreased phosphorylation of NTRK2 protein] CTD PMID:28499986 sulforaphane multiple interactions ISO RGD:731305 6480464 sulforafan inhibits the reaction [Pyruvaldehyde results in decreased expression of NTRK2 protein] CTD PMID:25933243 sulforaphane increases expression ISO RGD:731305 6480464 sulforafan results in increased expression of NTRK2 protein CTD PMID:25933243 T-2 Toxin decreases expression ISO RGD:731305 6480464 T-2 Toxin results in decreased expression of NTRK2 mRNA CTD PMID:31863870 tacrine multiple interactions ISO RGD:11023 6480464 [Tacrine co-treated with Scopolamine] results in increased phosphorylation of NTRK2 protein CTD PMID:31077737 tamibarotene multiple interactions ISO RGD:731305 6480464 [tamibarotene co-treated with BDNF] results in increased expression of NTRK2 CTD PMID:19182380 tamibarotene increases expression EXP 6480464 tamibarotene results in increased expression of NTRK2 CTD PMID:19182380 tamibarotene multiple interactions EXP 6480464 BDNF affects the reaction [tamibarotene results in increased phosphorylation of NTRK2 protein] CTD PMID:19457078 tamibarotene increases phosphorylation EXP 6480464 tamibarotene results in increased phosphorylation of NTRK2 protein CTD PMID:19457078 tert-butyl hydroperoxide decreases expression ISO RGD:731305 6480464 tert-Butylhydroperoxide results in decreased expression of NTRK2 mRNA CTD PMID:15336504 testosterone increases expression EXP 6480464 Testosterone results in increased expression of NTRK2 protein CTD PMID:17131419 Tetrachlorobisphenol A decreases expression ISO RGD:731305 6480464 tetrachlorodian results in decreased expression of NTRK2 mRNA CTD PMID:31326446 titanium dioxide affects expression ISO RGD:11023 6480464 titanium dioxide affects the expression of NTRK2 mRNA CTD PMID:23557971 toluene increases expression ISO RGD:11023 6480464 Toluene results in increased expression of NTRK2 mRNA CTD PMID:19932712 tranylcypromine increases expression EXP 6480464 Tranylcypromine results in increased expression of NTRK2 mRNA CTD PMID:8601816 triclosan increases expression ISO RGD:731305 6480464 Triclosan results in increased expression of NTRK2 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:11023 6480464 trimellitic anhydride results in decreased expression of NTRK2 mRNA CTD PMID:19042947 undecane increases expression EXP 6480464 undecane results in increased expression of NTRK2 protein CTD PMID:17337753 valproic acid increases expression ISO RGD:11023 6480464 Valproic Acid results in increased expression of NTRK2 mRNA CTD PMID:22045034 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of NTRK2 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:731305 6480464 Valproic Acid results in increased expression of NTRK2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:731305 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NTRK2 mRNA CTD PMID:27188386 venlafaxine hydrochloride decreases expression EXP 6480464 Venlafaxine Hydrochloride results in decreased expression of NTRK2 mRNA CTD PMID:25423262 vinclozolin multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NTRK2 mRNA CTD PMID:19015723 vorinostat decreases expression ISO RGD:731305 6480464 vorinostat results in decreased expression of NTRK2 mRNA CTD PMID:27188386 WIN 55212-2 multiple interactions ISO RGD:11023 6480464 [Acetaminophen co-treated with Win 55212-2] results in decreased expression of NTRK2 mRNA CTD PMID:30165669 zalcitabine multiple interactions EXP 6480464 [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of NTRK2 mRNA alternative form CTD PMID:18606552 zinc atom increases expression ISO RGD:731305 6480464 Zinc deficiency results in increased expression of NTRK2 mRNA CTD PMID:18356318 zinc atom decreases phosphorylation ISO RGD:11023 6480464 Zinc deficiency results in decreased phosphorylation of NTRK2 protein CTD PMID:20101602 zinc(0) increases expression ISO RGD:731305 6480464 Zinc deficiency results in increased expression of NTRK2 mRNA CTD PMID:18356318 zinc(0) decreases phosphorylation ISO RGD:11023 6480464 Zinc deficiency results in decreased phosphorylation of NTRK2 protein CTD PMID:20101602 zoledronic acid increases expression ISO RGD:731305 6480464 zoledronic acid results in increased expression of NTRK2 mRNA CTD PMID:24714768
Biological Process aging IEP 5684924 RGD brain-derived neurotrophic factor receptor signaling pathway IMP 1626132 RGD brain-derived neurotrophic factor receptor signaling pathway ISO RGD:11023 1624291 (MGI:MGI:5306304, PMID:16801538) RGD MGI:MGI:5306304 , PMID:16801538 brain-derived neurotrophic factor receptor signaling pathway IEA UniProtKB:Q16620 , ensembl:ENSP000002771201600115 GO_REF:0000107 Ensembl GO_REF:0000107 brain-derived neurotrophic factor receptor signaling pathway IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 brain-derived neurotrophic factor receptor signaling pathway IDA 8554094 PMID:8627351 UniProt brain-derived neurotrophic factor receptor signaling pathway IDA 8554777 PMID:1645620 UniProt brain-derived neurotrophic factor receptor signaling pathway ISO RGD:731305 1624291 (PMID:15494731) RGD PMID:15494731 calcium-mediated signaling using intracellular calcium source ISO RGD:11023 1624291 (MGI:MGI:5306316, PMID:14603320) RGD MGI:MGI:5306316 , PMID:14603320 cellular response to amino acid stimulus ISO RGD:11023 1624291 (MGI:MGI:5619875, PMID:25542970) RGD MGI:MGI:5619875 , PMID:25542970 cellular response to amino acid stimulus IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular response to brain-derived neurotrophic factor stimulus IEP 8657122 RGD cellular response to brain-derived neurotrophic factor stimulus IBA PANTHER:PTN002814914 , RGD:3213 13792537 PMID:21873635 GO_Central cellular response to nerve growth factor stimulus IEP 8657122 RGD cellular response to nerve growth factor stimulus IBA MGI:MGI:97383 more ... 13792537 PMID:21873635 GO_Central cellular response to tumor necrosis factor IEP 8657122 RGD central nervous system neuron development IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 central nervous system neuron development ISS UniProtKB:P15209 1600115 GO_REF:0000024 UniProt GO_REF:0000024 central nervous system neuron development ISO RGD:11023 1624291 (MGI:MGI:1343962, PMID:8402890) RGD MGI:MGI:1343962 , PMID:8402890 cerebral cortex development IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 cerebral cortex development ISS UniProtKB:P15209 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cerebral cortex development ISO RGD:11023 1624291 (MGI:MGI:3776308, PMID:15372074) RGD MGI:MGI:3776308 , PMID:15372074 circadian rhythm IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 circadian rhythm ISO RGD:11023 1624291 (PMID:23785138) RGD PMID:23785138 feeding behavior ISO RGD:11023 1624291 MGI:MGI:2384391 (MGI:MGI:2665156 , PMID:12796784) RGD MGI:MGI:2665156 , PMID:12796784 feeding behavior IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 glutamate secretion ISO RGD:11023 1624291 UniProtKB:P21237 (MGI:MGI:3654775 , PMID:16819522) RGD MGI:MGI:3654775 , PMID:16819522 glutamate secretion IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 inflammatory response IEP 8657122 RGD learning IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 learning ISS UniProtKB:P15209 1600115 GO_REF:0000024 UniProt GO_REF:0000024 learning ISO RGD:11023 1624291 (MGI:MGI:1346961, PMID:10571233) RGD MGI:MGI:1346961 , PMID:10571233 long-term memory IDA 5684780 RGD long-term synaptic potentiation IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 long-term synaptic potentiation ISO RGD:11023 1624291 (MGI:MGI:3772008, PMID:12367511) RGD MGI:MGI:3772008 , PMID:12367511 mechanoreceptor differentiation ISO RGD:11023 1624291 MGI:MGI:1857814 (MGI:MGI:3505841 , PMID:15376326) RGD MGI:MGI:3505841 , PMID:15376326 mechanoreceptor differentiation IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 multicellular organism development IBA FB:FBgn0003733 more ... 13792537 PMID:21873635 GO_Central myelination in peripheral nervous system IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 myelination in peripheral nervous system ISO RGD:11023 1624291 MGI:MGI:97385 more ... RGD MGI:MGI:4818716 , PMID:20553714 negative regulation of amyloid-beta formation ISO RGD:731305 1624291 UniProtKB:P05067-4 (PMID:26094765) RGD PMID:26094765 negative regulation of amyloid-beta formation IEA UniProtKB:Q16620 , ensembl:ENSP000002771201600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of anoikis IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of anoikis ISO RGD:11023 1624291 (MGI:MGI:5306312, PMID:15329723) RGD MGI:MGI:5306312 , PMID:15329723 negative regulation of neuron apoptotic process IMP 8553408 PMID:10985347 UniProt nervous system development IBA FB:FBgn0010407 more ... 13792537 PMID:21873635 GO_Central neuromuscular junction development ISO RGD:11023 1624291 MGI:MGI:1857814 (MGI:MGI:1349225 , PMID:10595510) RGD MGI:MGI:1349225 , PMID:10595510 neuron differentiation ISO RGD:11023 1624291 (MGI:MGI:3776308, PMID:15372074) RGD MGI:MGI:3776308 , PMID:15372074 neuron differentiation ISS UniProtKB:P15209 1600115 GO_REF:0000024 UniProt GO_REF:0000024 neuron migration IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuron migration ISS UniProtKB:P15209 1600115 GO_REF:0000024 UniProt GO_REF:0000024 neuron migration ISO RGD:11023 1624291 (MGI:MGI:3776308, PMID:15372074) RGD MGI:MGI:3776308 , PMID:15372074 neuronal action potential propagation IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuronal action potential propagation ISO RGD:11023 1624291 MGI:MGI:97385 more ... RGD MGI:MGI:4818716 , PMID:20553714 neurotrophin signaling pathway IEA GO:0005030 1600115 GO_REF:0000108 GOC GO_REF:0000108 oligodendrocyte differentiation ISO RGD:11023 1624291 (MGI:MGI:3776308, PMID:15372074) RGD MGI:MGI:3776308 , PMID:15372074 oligodendrocyte differentiation IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 peptidyl-tyrosine phosphorylation IEA GO:0004714 1600115 GO_REF:0000108 GOC GO_REF:0000108 peptidyl-tyrosine phosphorylation IEA GO:0004713 1600115 GO_REF:0000108 GOC GO_REF:0000108 peripheral nervous system neuron development ISO RGD:11023 1624291 (MGI:MGI:1343962, PMID:8402890) RGD MGI:MGI:1343962 , PMID:8402890 peripheral nervous system neuron development IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of axonogenesis IMP 8553408 PMID:10985347 UniProt positive regulation of cell population proliferation IDA 8554617 PMID:9582017 UniProt positive regulation of ERK1 and ERK2 cascade NOT IBA PANTHER:PTN002400475 , UniProtKB:P04629 13792537 PMID:21873635 GO_Central positive regulation of gene expression ISO RGD:11023 1624291 (MGI:MGI:3772008, PMID:12367511) RGD MGI:MGI:3772008 , PMID:12367511 positive regulation of gene expression ISS UniProtKB:P15209 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of gene expression IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of glucocorticoid receptor signaling pathway IGI UniProtKB:P23363 10047172 PMID:23878391 MGI positive regulation of kinase activity IBA PANTHER:PTN001230349 , UniProtKB:Q16832 13792537 PMID:21873635 GO_Central positive regulation of MAPK cascade IMP 8553408 PMID:10985347 UniProt positive regulation of MAPK cascade IBA PANTHER:PTN002400475 more ... 13792537 PMID:21873635 GO_Central positive regulation of neuron projection development ISO RGD:11023 1624291 (MGI:MGI:5306304, PMID:16801538) RGD MGI:MGI:5306304 , PMID:16801538 positive regulation of neuron projection development ISS UniProtKB:P15209 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of neuron projection development IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of neuron projection development IBA MGI:MGI:97384 more ... 13792537 PMID:21873635 GO_Central positive regulation of peptidyl-serine phosphorylation ISO RGD:11023 1624291 (MGI:MGI:5543306, PMID:23878391) RGD MGI:MGI:5543306 , PMID:23878391 positive regulation of peptidyl-serine phosphorylation IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of phosphatidylinositol 3-kinase signaling IMP 8553408 PMID:10985347 UniProt positive regulation of phosphatidylinositol 3-kinase signaling IBA PANTHER:PTN002400475 , RGD:3213 13792537 PMID:21873635 GO_Central positive regulation of synapse assembly ISO RGD:11023 1624291 (MGI:MGI:5576449, PMID:24613359) RGD MGI:MGI:5576449 , PMID:24613359 positive regulation of synapse assembly IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of synaptic transmission, glutamatergic IMP 1626130 RGD protein autophosphorylation IMP 1626134 RGD protein autophosphorylation IDA 8554617 PMID:9582017 UniProt regulation of dendrite development IMP 1626132 RGD regulation of GTPase activity IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of GTPase activity ISS UniProtKB:P15209 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of GTPase activity ISO RGD:11023 1624291 (MGI:MGI:5306304, PMID:16801538) RGD MGI:MGI:5306304 , PMID:16801538 regulation of MAPK cascade IDA 8554617 PMID:9582017 UniProt regulation of MAPK cascade IBA PANTHER:PTN002400475 more ... 13792537 PMID:21873635 GO_Central regulation of metabolic process ISO RGD:11023 1624291 MGI:MGI:2384391 (MGI:MGI:2665156 , PMID:12796784) RGD MGI:MGI:2665156 , PMID:12796784 regulation of neurotransmitter secretion IDA 1626131 RGD regulation of protein kinase B signaling IBA MGI:MGI:97384 , PANTHER:PTN000698829 13792537 PMID:21873635 GO_Central regulation of protein kinase B signaling ISO RGD:11023 1624291 (MGI:MGI:3776308, PMID:15372074) RGD MGI:MGI:3776308 , PMID:15372074 regulation of protein kinase B signaling IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to auditory stimulus IEP 5684781 RGD response to light stimulus IEP 8655603 RGD retina development in camera-type eye ISO RGD:11023 1624291 (MGI:MGI:5619875, PMID:25542970) RGD MGI:MGI:5619875 , PMID:25542970 retinal rod cell development ISO RGD:11023 1624291 MGI:MGI:3039928 (MGI:MGI:3039190 , PMID:10516311) RGD MGI:MGI:3039190 , PMID:10516311 retinal rod cell development IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 trans-synaptic signaling by BDNF, modulating synaptic transmission ISO RGD:11023 1624291 (MGI:MGI:5661287, PMID:24991961) RGD MGI:MGI:5661287 , PMID:24991961 trans-synaptic signaling by neuropeptide, modulating synaptic transmission IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 trans-synaptic signaling by neuropeptide, modulating synaptic transmission IBA MGI:MGI:97384 , PANTHER:PTN002814914 13792537 PMID:21873635 GO_Central trans-synaptic signaling by neuropeptide, modulating synaptic transmission ISO RGD:11023 1624291 (MGI:MGI:5661287, PMID:24991961) RGD MGI:MGI:5661287 , PMID:24991961 transmembrane receptor protein serine/threonine kinase signaling pathway IEA GO:0004675 1600115 GO_REF:0000108 GOC GO_REF:0000108 transmembrane receptor protein tyrosine kinase signaling pathway IBA FB:FBgn0003366 more ... 13792537 PMID:21873635 GO_Central vasculogenesis ISO RGD:11023 1624291 MGI:MGI:1857814 (MGI:MGI:3607478 , PMID:16264195) RGD MGI:MGI:3607478 , PMID:16264195 vasculogenesis IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cellular Component axon IDA 1626129 RGD axon IBA MGI:MGI:97383 more ... 13792537 PMID:21873635 GO_Central axon IDA 13673858 PMID:21775604 UniProt axon terminus IDA 2303068 RGD axon terminus IBA MGI:MGI:97384 more ... 13792537 PMID:21873635 GO_Central cell surface IDA 1626129 RGD cytoplasm IDA 8655603 RGD cytosol ISO RGD:11023 1624291 (MGI:MGI:2157583, PMID:11083466) RGD MGI:MGI:2157583 , PMID:11083466 cytosol IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 dendrite IDA 1626129 RGD dendrite IDA 13673858 PMID:21775604 UniProt dendritic spine IDA 2303068 RGD dendritic spine IBA PANTHER:PTN000699897 , RGD:3213 13792537 PMID:21873635 GO_Central dendritic spine IDA 12050128 PMID:25632160 SynGO early endosome ISO RGD:11023 1624291 (MGI:MGI:5825424, PMID:21849472) RGD MGI:MGI:5825424 , PMID:21849472 early endosome ISS UniProtKB:P15209 1600115 GO_REF:0000024 UniProt GO_REF:0000024 early endosome IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 early endosome membrane IEA UniProtKB-SubCell:SL-0093 1600115 GO_REF:0000044 UniProt GO_REF:0000044 endosome ISO RGD:11023 1624291 (MGI:MGI:5515840, PMID:24035762) RGD MGI:MGI:5515840 , PMID:24035762 excitatory synapse IDA 1626129 RGD glutamatergic synapse IDA 12050128 PMID:25632160 SynGO glutamatergic synapse IMP 12050128 PMID:25632160 SynGO Golgi membrane TAS 1600115 Reactome:R-RNO-189618 Reactome Reactome:R-RNO-189618 Golgi membrane TAS 1600115 Reactome:R-RNO-9613024 Reactome Reactome:R-RNO-9613024 Golgi membrane TAS 1600115 Reactome:R-RNO-9613030 Reactome Reactome:R-RNO-9613030 Golgi membrane TAS 1600115 Reactome:R-RNO-189632 Reactome Reactome:R-RNO-189632 growth cone IDA 1626129 RGD integral component of plasma membrane ISO RGD:731305 1624291 (PMID:15494731) RGD PMID:15494731 integral component of plasma membrane IBA FB:FBgn0003366 more ... 13792537 PMID:21873635 GO_Central integral component of plasma membrane IEA UniProtKB:Q16620 , ensembl:ENSP000002771201600115 GO_REF:0000107 Ensembl GO_REF:0000107 integral component of plasma membrane IDA 8554777 PMID:1645620 UniProt neuronal cell body IDA 1626129 RGD perikaryon IDA 8655644 RGD perinuclear region of cytoplasm IDA 13673858 PMID:21775604 UniProt plasma membrane IDA 1626129 RGD plasma membrane TAS 1600115 Reactome:R-RNO-198717 Reactome Reactome:R-RNO-198717 plasma membrane TAS 1600115 Reactome:R-RNO-188339 Reactome Reactome:R-RNO-188339 plasma membrane TAS 1600115 Reactome:R-RNO-187759 Reactome Reactome:R-RNO-187759 plasma membrane TAS 1600115 Reactome:R-RNO-187713 Reactome Reactome:R-RNO-187713 plasma membrane TAS 1600115 Reactome:R-RNO-182091 Reactome Reactome:R-RNO-182091 plasma membrane TAS 1600115 Reactome:R-RNO-182060 Reactome Reactome:R-RNO-182060 plasma membrane TAS 1600115 Reactome:R-RNO-182053 Reactome Reactome:R-RNO-182053 plasma membrane TAS 1600115 Reactome:R-RNO-182041 Reactome Reactome:R-RNO-182041 plasma membrane TAS 1600115 Reactome:R-RNO-182040 Reactome Reactome:R-RNO-182040 plasma membrane TAS 1600115 Reactome:R-RNO-182018 Reactome Reactome:R-RNO-182018 plasma membrane TAS 1600115 Reactome:R-RNO-181835 Reactome Reactome:R-RNO-181835 plasma membrane TAS 1600115 Reactome:R-RNO-181827 Reactome Reactome:R-RNO-181827 plasma membrane TAS 1600115 Reactome:R-RNO-181812 Reactome Reactome:R-RNO-181812 plasma membrane TAS 1600115 Reactome:R-RNO-181799 Reactome Reactome:R-RNO-181799 plasma membrane TAS 1600115 Reactome:R-RNO-177478 Reactome Reactome:R-RNO-177478 plasma membrane ISO RGD:11023 1624291 (MGI:MGI:2662800 more ... RGD MGI:MGI:2662800 more ... plasma membrane TAS 1600115 Reactome:R-NUL-9032387 Reactome Reactome:R-NUL-9032387 plasma membrane TAS 1600115 Reactome:R-NUL-9032361 Reactome Reactome:R-NUL-9032361 plasma membrane TAS 1600115 Reactome:R-NUL-9031077 Reactome Reactome:R-NUL-9031077 plasma membrane TAS 1600115 Reactome:R-NUL-9030450 Reactome Reactome:R-NUL-9030450 plasma membrane TAS 1600115 Reactome:R-NUL-9030397 Reactome Reactome:R-NUL-9030397 plasma membrane TAS 1600115 Reactome:R-NUL-9031971 Reactome Reactome:R-NUL-9031971 plasma membrane TAS 1600115 Reactome:R-RNO-9037056 Reactome Reactome:R-RNO-9037056 plasma membrane TAS 1600115 Reactome:R-RNO-9032619 Reactome Reactome:R-RNO-9032619 plasma membrane TAS 1600115 Reactome:R-RNO-9032590 Reactome Reactome:R-RNO-9032590 plasma membrane TAS 1600115 Reactome:R-RNO-9032568 Reactome Reactome:R-RNO-9032568 plasma membrane TAS 1600115 Reactome:R-RNO-9030763 Reactome Reactome:R-RNO-9030763 plasma membrane TAS 1600115 Reactome:R-RNO-9030518 Reactome Reactome:R-RNO-9030518 plasma membrane TAS 1600115 Reactome:R-RNO-9030485 Reactome Reactome:R-RNO-9030485 plasma membrane TAS 1600115 Reactome:R-NUL-9032961 Reactome Reactome:R-NUL-9032961 plasma membrane TAS 1600115 Reactome:R-NUL-9032516 Reactome Reactome:R-NUL-9032516 plasma membrane TAS 1600115 Reactome:R-NUL-9032423 Reactome Reactome:R-NUL-9032423 plasma membrane TAS 1600115 Reactome:R-NUL-9032945 Reactome Reactome:R-NUL-9032945 plasma membrane TAS 1600115 Reactome:R-NUL-9032399 Reactome Reactome:R-NUL-9032399 plasma membrane TAS 1600115 Reactome:R-NUL-9032908 Reactome Reactome:R-NUL-9032908 plasma membrane TAS 1600115 Reactome:R-NUL-9030372 Reactome Reactome:R-NUL-9030372 plasma membrane TAS 1600115 Reactome:R-RNO-182072 Reactome Reactome:R-RNO-182072 postsynapse IDA 12050128 PMID:25632160 SynGO postsynapse IMP 12050128 PMID:25632160 SynGO postsynaptic density IDA 1626131 ; 5147998 RGD postsynaptic density ISO RGD:11023 1624291 (MGI:MGI:3531596 more ... RGD MGI:MGI:3531596 more ... postsynaptic density IBA MGI:MGI:97384 more ... 13792537 PMID:21873635 GO_Central postsynaptic density IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 postsynaptic membrane ISO RGD:11023 1624291 (MGI:MGI:1349225, PMID:10595510) RGD MGI:MGI:1349225 , PMID:10595510 presynaptic active zone IDA 1626131 RGD receptor complex ISO RGD:731305 1624291 (PMID:23382219) RGD PMID:23382219 receptor complex IBA FB:FBgn0015380 more ... 13792537 PMID:21873635 GO_Central receptor complex IEA UniProtKB:Q16620 , ensembl:ENSP000002771201600115 GO_REF:0000107 Ensembl GO_REF:0000107 rough endoplasmic reticulum IDA 8655644 RGD terminal bouton ISO RGD:11023 1624291 (MGI:MGI:3654775, PMID:16819522) RGD MGI:MGI:3654775 , PMID:16819522 terminal bouton IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 Molecular Function ATP binding IEA UniProtKB-KW:KW-0067 1600115 GO_REF:0000043 UniProt GO_REF:0000043 brain-derived neurotrophic factor binding IDA 1626131 RGD brain-derived neurotrophic factor binding IBA MGI:MGI:97384 more ... 13792537 PMID:21873635 GO_Central brain-derived neurotrophic factor binding ISO RGD:11023 1624291 (MGI:MGI:893826, PMID:1645620) RGD MGI:MGI:893826 , PMID:1645620 brain-derived neurotrophic factor binding IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 brain-derived neurotrophic factor binding IDA 8554777 PMID:1645620 UniProt brain-derived neurotrophic factor binding IMP 1626130 RGD brain-derived neurotrophic factor-activated receptor activity ISO RGD:731305 1624291 (PMID:15494731) RGD PMID:15494731 brain-derived neurotrophic factor-activated receptor activity IBA MGI:MGI:97384 more ... 13792537 PMID:21873635 GO_Central brain-derived neurotrophic factor-activated receptor activity IEA UniProtKB:Q16620 , ensembl:ENSP000002771201600115 GO_REF:0000107 Ensembl GO_REF:0000107 brain-derived neurotrophic factor-activated receptor activity IEA UniProtKB:P15209 , ensembl:ENSMUSP000000787571600115 GO_REF:0000107 Ensembl GO_REF:0000107 brain-derived neurotrophic factor-activated receptor activity ISO RGD:11023 1624291 (MGI:MGI:5306304, PMID:16801538) RGD MGI:MGI:5306304 , PMID:16801538 brain-derived neurotrophic factor-activated receptor activity IDA 8554094 PMID:8627351 UniProt brain-derived neurotrophic factor-activated receptor activity IDA 8554777 PMID:1645620 UniProt neurotrophin binding ISO RGD:731305 1624291 (PMID:11738045) RGD PMID:11738045 neurotrophin binding IBA MGI:MGI:97384 more ... 13792537 PMID:21873635 GO_Central neurotrophin binding ISS UniProtKB:Q16620 1600115 GO_REF:0000024 UniProt GO_REF:0000024 neurotrophin binding ISO RGD:11023 1624291 (MGI:MGI:893826, PMID:1645620) RGD MGI:MGI:893826 , PMID:1645620 neurotrophin binding IDA 8554777 PMID:1645620 UniProt neurotrophin receptor activity IMP 1626130 RGD neurotrophin receptor activity IBA MGI:MGI:97384 more ... 13792537 PMID:21873635 GO_Central neurotrophin receptor activity IDA 1626131 RGD protease binding ISO RGD:731305 1624291 UniProtKB:P49768 , UniProtKB:Q92542 (PMID:26094765) RGD PMID:26094765 protease binding IEA UniProtKB:Q16620 , ensembl:ENSP000002771201600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein binding IPI RGD:2625 2302981 RGD protein binding IPI UniProtKB:Q9ESN9 13673858 PMID:21775604 UniProt protein binding IPI UniProtKB:P37285 13673858 PMID:21775604 UniProt protein binding IPI UniProtKB:E9PSK7 13673858 PMID:21775604 UniProt protein binding IPI UniProtKB:P06536 13432268 PMID:19126684 IntAct protein binding IPI UniProtKB:Q03114 13432345 PMID:17341134 IntAct protein binding IPI UniProtKB:Q04631 2302981 PMID:18957540 IntAct protein binding IPI UniProtKB:Q8K4V6 8554762 PMID:21364532 IntAct protein binding ISO RGD:11023 1624291 PR:P20181 more ... RGD MGI:MGI:2152295 more ... protein binding IPI UniProtKB:Q5M824 8554617 PMID:9582017 UniProt protein binding ISO RGD:731305 1624291 UniProtKB:P34130 , UniProtKB:Q03114 (PMID:17341134), (PMID:25241761), (PMID:29997244) RGD PMID:17341134 more ... protein homodimerization activity IDA 8554094 PMID:8627351 UniProt protein tyrosine kinase activity TAS 1600115 Reactome:R-NUL-9032945 Reactome Reactome:R-NUL-9032945 receptor tyrosine kinase binding IPI RGD:1307455 10043330 RGD transmembrane receptor protein serine/threonine kinase activity TAS 1600115 Reactome:R-RNO-198717 Reactome Reactome:R-RNO-198717 transmembrane receptor protein tyrosine kinase activity IMP 1626134 RGD transmembrane receptor protein tyrosine kinase activity IBA FB:FBgn0003366 more ... 13792537 PMID:21873635 GO_Central
Gene-Chemical Interaction Annotations
